Literature DB >> 15265895

IFN-alpha subtypes differentially affect human T cell motility.

Graham R Foster1, Siti H Masri, Rachel David, Meleri Jones, Arpita Datta, Giovanna Lombardi, Laura Runkell, Carole de Dios, Irene Sizing, Martha J James, Federica M Marelli-Berg.   

Abstract

The type I IFN family includes 14 closely related antiviral cytokines that are produced in response to viral infections. They bind to a common receptor, and have qualitatively similar biological activities. The physiological relevance of this redundancy is still unclear. In this study, we analyzed and compared the effects of two potent antiviral type I IFNs, IFN-alpha 2 and IFN-alpha 8, on the motility of various populations of human T lymphocytes in vitro. In this study, we show that IFN-alpha 2 induces chemokinesis of both CD4(+) and CD8(+) T cells at various stages of differentiation, and induces functional changes that result in enhanced T cell motility, including up-regulation of the integrins LFA-1 and VLA-4, and subsequently, increased ICAM-1- and fibronectin-dependent migration. In contrast, IFN-alpha 8 did not affect T cell motility, despite having similar antiviral properties and similar effects on the induction of the antiviral protein MxA. However, transcription of other IFN-stimulated genes showed that transcription of these genes is selectively activated by IFN-alpha 2, but not IFN-alpha 8, in T cells. Finally, while the antiviral activity of the two subtypes is inhibited by Abs against the two subunits of the IFN-alpha receptor, the chemokinetic effect of IFN-alpha 2 is selectively blocked by Abs against the A1 receptor subunit. These observations are consistent with the possibility that subtype-specific intracellular signaling pathways are activated by type I IFNs in T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265895     DOI: 10.4049/jimmunol.173.3.1663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells.

Authors:  Richard Szubin; W L William Chang; Tamara Greasby; Laurel Beckett; Nicole Baumgarth
Journal:  J Interferon Cytokine Res       Date:  2008-12       Impact factor: 2.607

2.  Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

Authors:  A Tamir; W J Jordan; M Ritter; N Habib; R I Lechler; G R Foster; G Lombardi
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.

Authors:  Marlena M Westcott; Jingfang Liu; Karishma Rajani; Ralph D'Agostino; Douglas S Lyles; Mercedes Porosnicu
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

5.  Age-related differences in integrin expression in peripheral blood lymphocytes.

Authors:  Christine V Crooks; Martin L Cross; Clare R Wall
Journal:  Immun Ageing       Date:  2010-04-26       Impact factor: 6.400

Review 6.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

7.  Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.

Authors:  Amy D Brideau-Andersen; Xiaojian Huang; Siu-Chi Chang Sun; Teddy T Chen; Diane Stark; Ian J Sas; Linda Zadik; Glenn N Dawes; Douglas R Guptill; Robert McCord; Sridhar Govindarajan; Ajoy Roy; Shumin Yang; Judy Gao; Yong Hong Chen; Niels Jørgen Ø Skartved; Annette K Pedersen; David Lin; Christopher P Locher; Indrani Rebbapragada; Anne Dam Jensen; Steven H Bass; Torben L Straight Nissen; Sridhar Viswanathan; Graham R Foster; Julian A Symons; Phillip A Patten
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

Review 8.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 9.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

10.  Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease.

Authors:  Wenwen Yan; Siwan Wen; Lemin Wang; Qianglin Duan; Lin Ding
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.